In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it’s been common for lawyers to try to overturn patents held by competitors by pointing out errors or inconsistencies.

Two Nobel Prize winners want to cancel their own CRISPR patents in Europe In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it’s been common for lawyers to try to ...

在长达十年的 CRISPR（修改 DNA 的超级工具）专利之争中，律师经常试图通过指出错误或不一致来推翻竞争对手持有的专利。 但现在，出现了令人惊讶 ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will ...

A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a ...

The Federal Circuit's opinion has yet to come out. Meanwhile, in Europe, Emmanuelle Charpentier and Jennifer Doudna, who won the Nobel Prize for their work on CRISPR technology, asked the EPO to ...

The deal comes after a long legal battle over who owns key patents for CRISPR technology, which was discovered by several researchers and the basis of the 2020 Nobel Prize in Chemistry that was ...

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to ...